John Drake, MD
Urology · Atlanta, GANPI 1689855074
Payments from drug & device makers
Across 31 payments — averaging $262.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Boston Scientific$631
- Teleflex LLC$249
- Procept Biorobotics Corporation$172
- C. R. Bard, Inc. & Subsidiaries$79
- Calyxo, Inc.$50
- plus $86 from 4 others
What the payments were for
- Food & beverage$1,39717%
- Education$6,75083%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $6,881 |
| Boston Scientific | 10 | $631 |
| Teleflex LLC | 5 | $249 |
| Procept Biorobotics Corporation | 3 | $172 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $79 |
| Calyxo, Inc. | 1 | $50 |
| Innovation Technologies Inc | 1 | $25 |
| Endo USA, Inc. | 1 | $23 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
| Coloplast | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,750
- LithoVue$138
- LITHOCLAST$129
- Tria Firm$121
- SpaceOAR VUE System - 10mL$105
How this compares
$8,147 in reported general payments places this provider in the 70th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 33 | $26,789 |
| GemtesaVibegron | 19 | $10,100 |
| Tamsulosin Hcl | 233 | $2,829 |
| Darifenacin ErDarifenacin Hydrobromide | 33 | $2,311 |
| Finasteride | 157 | $1,951 |
| Trospium Chloride | 45 | $1,536 |
| Trimethoprim | 12 | $735 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 27 | $493 |
| Cephalexin | 27 | $244 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $239 |
| Ciprofloxacin Hcl | 39 | $210 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 30 | $181 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $78 |
Paid to pharmacies, not to this prescriber.
Other urology in Atlanta
- Viraj MasterAtlanta$2M
- Vikram NarayanAtlanta$1.1M
- Kenneth OganAtlanta$425K
- Tariq HakkyAtlanta$140K
- Shreyas JoshiAtlanta$98K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
- Matthew SandAtlanta$77K
- Brendan BrowneAtlanta$53K
- John PattarasAtlanta$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.